Condoluci A, Romano I, Dietrich D, Pini K, et al. Ibrutinib Lead-in followed by Venetoclax Plus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia - SAKK 34/17. Blood 2025 Feb 26:blood.2024026879. doi: 10.1182/blood.2024026879.
PMID: 40009495